Companies
Illumina
Life sciences toolsSan Diego, CaliforniaILMNAbout 8,600 employees
More about Illumina
Maker of DNA sequencing instruments, consumables and software for research, clinical and applied genomics
Revenue
$4.34B
Fiscal 2025, down about 1%
Employees
About 8,600
As of December 2025, full-time
Stock
ILMN
Nasdaq
Headquarters
San Diego, California
CEO
Jacob Thaysen
Since September 2023
Main businessesSequencing instruments, consumables, library preparation and bioinformatics software
Current strategyPushing into clinical and translational markets with sequencing and sample-to-answer tests in oncology, genetic health and reproductive health, while cutting costs
Recent workforce changes96 roles cut at its San Diego headquarters between April and August 2025
CompetitorsThermo Fisher Scientific, Pacific Biosciences, Element Biosciences
Related companiesThermo Fisher ScientificDanaher
Checked October 11, 2026 · Sources: sec.gov, medtechdive.com
No source-backed updates for Illumina yet. They appear here when a public report or filing covers the company.
No one has posted about Illumina yet. Be the first to post ›
Follow Illumina in a feed reader, no account needed: RSS feed